MANAGEMENT OF COVID ASSOCIATED ORBITAL MUCORMYCOSIS IN TERTIARY CARE HOSPITAL

Objectives: The aim of the study was to epidemiological characteristics and management orbital mucormycosis in cases rhino-orbital tertiary care hospital. Methods: It is a retrospective 258 patients presenting KGH, Visakhapatnam, over duration 3 months from June August 2021. After taking detailed history regarding symptoms mucormycosis, visual acuity noted, slit lamp examination done necessary investigations such as microbiology, pathology specimens were sent analyzed, imaging done, accordingly. Results: majority came with ENT-related treated endoscopic debridement, that is, 216 (84%), debridement decompression 23 (9%), transcutaneous retrobulbar amphotericin B 21 (8%), exenteration 17 (6.5%), total partial maxillectomy 28 (10.8%), temporal lobe abscess drainage 7 (2.7%), frontal (1.16%), bone dural 6 (2.3%), 15 (5.8) conservatively, 30 (11.6%) death. Conclusion: COVID-19 infection presence glycemic dysregulation predisposes development Rhino-orbital-cerebral mucormycosis. Strict control judicious use corticosteroids might help decrease incidence cases. Most presents if not early may spread orbit intracranial sites. Early treatment during presentation prevent spreading extension extension.